Director/PDMR Shareholding

Indivior

27/02/2025 16:29

RNS Number : 7706Y

Indivior PLC

27 February 2025

 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that it received notification on February 27, 2025 that Dr. David Wheadon,  Chair of the Company, acquired a total of 10,000 Ordinary Shares of US$0.50 each in the Company ('Shares') at an average price of $8.4281 per share on February 27, 2025.

Following this transaction, Dr. Wheadon has an interest in 10,000 shares in the Company.

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr. David Wheadon
2
Reason for the notification
a)
Position/status
Chair
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Indivior PLC
b)
LEI
213800V3NCQTY7IED471
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of US$0.50
GB00BN4HT335
b)
Nature of the transaction
Purchase of Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
$8.4281
10,000
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
February 27, 2025
f)
Place of the transaction
Nasdaq Global Select Market


 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHPPURPPUPAGQM